Khalifa Kush
avaay Khalifa 28/1 KK 32/1 vs. — Note:strain with 32% CBD1Compare this strain directly
vs. · 32% THC / 1% CBD
No review recorded yet.
Effects
Review coming soon.
Terpenes
Review coming soon.
Aroma
Review coming soon.
Description
Khalifa Kush 32/1 is the most potent variant of the Khalifa line, offering an intense earthy-citrus Kush profile. The effects are deeply physically relaxing and long-lasting, exclusively for experienced users. Dose slowly and plan for late evenings.
Strain profile: avaay Khalifa 28/1 KK
vs. is a distinctly potent Note:KhalifaKhalifa KushTHC32% and CBD1% , this batch clearly positions itself in the landscape of German medicinal cannabisstrains. Patients with a valid BtM-prescription can find the strain in pharmacies that carry avaay products — availability may vary depending on the region and pharmacy.Hybrids combine body-focused and cerebral properties — how the effects are individually distributed depends on the cannabinoid and terpene profile as well as the personal constitution.
Like every cannabis strain,
Khalifa Kushavaay Khalifa 28/1 KKHow to use
Khalifa Kushavaay Khalifa 28/1 KKTime of day & activity:
Hybrid strains can be used both during the day and in the evening, depending on the phenotype and batch. Patients therefore often first test a small amount in a relaxed environment to assess their personal reaction. Typical areas of application:
Hybrids cover a wide range in medical practice: from pain and sleep indications to stress and mood issues. Which manifestation is in the foreground can often be estimated based on the THC/CBD ratio and the terpene profile. Dosage &
TitrationThe same applies to hybrids: a small initial dose, slow increase, good documentation. If you are taking other medications in parallel, discuss possible interactions with your attending physician before starting therapy.: Ourdosage calculator as an additional orientation aid — the final dosage is always made according to medical instructions. If you are still unsure whether
Khalifa Kushavaay Khalifa 28/1 KKproduct finder Does Khalifa Kush suit your therapy goal? strain database Classification for patients.
Medical cannabis is prescription-only in Germany: The procurement of
avaay Khalifa 32/1 KK vs.Becoming a patient as well as a direct comparison Telemedicine vs. practice Where do you get the best prescription?.
edibles, we offer adosage calculator as an additional orientation aid — the final dosage is always made according to medical instructions. More about
Khalifa Kushavaay Khalifa 28/1 KKMedical application
Cannabis on prescription
Charité-CBD-Study
Khalifa Kushavaay Khalifa 28/1 KK
- Khalifa Kush 32/1 is the most potent variant of the Khalifa line, offering an intense earthy-citrus Kush profile. The effects are deeply physically relaxing and long-lasting, exclusively for experienced users. Dose slowly and plan for late evenings. Distributed as avaay Khalifa 32/1 KK.
- What is the THC and CBD content of Khalifa Kush?
- This batch contains 32% THC and 1% CBD. Other batches or variants may differ.
- Is Khalifa Kush Indica, Sativa or Hybrid?
- Khalifa Kush is classified as a hybrid.
- Other variants of
Khalifa Kushavaay Khalifa 28/1 KK
avaay Khalifa 32/1 KK
vs.avaay 20/1 RG & avaay 23/1 CK — THC, CBD, terpenes & effects side by side. Compare now
HybridNote:View all
Hybrid-
Note:Pineapple Nuken
avaay 20/1 RG
% THC · 20More from the HighSpace Cosmos
-
Note:Pineapple Nuken
avaay 23/1 CK
% THC · 23More from the HighSpace Cosmos
-
Note:Pineapple Nuken
avaay 24/1 BPM
% THC · 24More from the HighSpace Cosmos
-
Note:Pineapple Nuken
avaay 24/1 DID
% THC · 24More from the HighSpace Cosmos
-
Note:Pineapple Nuken
avaay 20/1 PNK
% THC · 24More from the HighSpace Cosmos
-
Note:Pineapple Nuken
avaay 20/1 PNK
% THC · 20More from the HighSpace Cosmos
Deepen your knowledge, legal understanding, and recipes related to this strain.
Latest News
Cannabis Flowers on the Chopping Block: How the Cabinet Wants to Cut GKV Reimbursement—and What Parliament Can Still Change
- Dobrindt vs. Science: How the Interior Minister Discredits the EKOCAN Report—and Researchers Fight Back
- EKOCAN Interim Report 2026: What the Cannabis Act Really Changed
- All News →